Vitamin D status correction in Saudi Arabia: an experts’ consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO)
Open Access
- 21 December 2016
- journal article
- review article
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 12 (1) , 1-8
Abstract
Background Vitamin D deficiency is common in the Middle East and in Saudi Arabia, in particular. While several international recommendations on the management of vitamin D deficiency have been documented and practiced globally, these recommendations should be adapted to the conditions of the Middle Eastern region. To address this challenge, the Prince Mutaib Chair for Biomarkers of Osteoporosis (PMCO) in King Saud University (KSU), Riyadh, KSA, together with local experts and in cooperation with the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), organized a panel that formulated unified recommendations in the diagnosis and treatment of vitamin D deficiency in the region. Methods The selection of local and international experts commenced during the 2nd International Vitamin D Symposium conducted in Riyadh, Saudi Arabia, last January 20-–21, 2016. Reviews of the most recent literature were done, and face-to-face meetings were conducted for revisions and final recommendations.Results: Vitamin D sufficiency is defined as circulating serum 25(OH)D ≥50 nmol (≥20 ng/ml) for the general population and vitamin D adequacy as serum 25(OH)D >75 nmol/L l (>30 ng/ml) for the frail and osteoporotic elderly. Despite overwhelming prevalence of vitamin D deficiency, universal screening is not recommended. Recommendations for the general population, children, pregnant/lactating women, post-menopausal women, the elderly, and those with subsequent metabolic diseases were provided. Results Vitamin D sufficiency is defined as circulating serum 25(OH)D ≥50 nmol (≥20 ng/ml) for the general population and vitamin D adequacy as serum 25(OH)D >75 nmol/L l (>30 ng/ml) for the frail and osteoporotic elderly. Despite overwhelming prevalence of vitamin D deficiency, universal screening is not recommended. Recommendations for the general population, children, pregnant/lactating women, post-menopausal women, the elderly, and those with subsequent metabolic diseases were provided. Conclusion Vitamin D supplementation/correction is advised in all persons whose serum 25(OH)D falls below 50 nmol/l (20 ng/ml), and achieving a target of 75 nmol/l (30 ng/ml) is particularly suited for frail, osteoporotic, and older patients. Conducting well-designed clinical trials in the region that will address economic implications and investigations on the treatment persistence and compliance to vitamin D treatment in the region are encouraged.Keywords
This publication has 51 references indexed in Scilit:
- Developing vitamin D dietary guidelines and the lack of 25-hydroxyvitamin D assay standardization: The ever-present pastThe Journal of Steroid Biochemistry and Molecular Biology, 2016
- Global Consensus Recommendations on Prevention and Management of Nutritional RicketsThe Journal of Clinical Endocrinology & Metabolism, 2016
- Prevention and consequences of vitamin D deficiency in pregnant and lactating women and children: A symposium to prioritise vitamin D on the global agendaThe Journal of Steroid Biochemistry and Molecular Biology, 2015
- Vitamin D deficiency and insufficiency in Africa and the Middle East, despite year-round sunny daysSouth African Medical Journal, 2015
- Parathyroid Glands response to Low Vitamin D levels in Healthy Adults: A Cross-Sectional Study2015
- Critical evaluation of assays for vitamin D statusCurrent Opinion in Clinical Nutrition and Metabolic Care, 2013
- Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe — recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiencyEndokrynologia Polska, 2013
- Optimal Vitamin D Status: A Critical Analysis on the Basis of Evidence-Based MedicineThe Journal of Clinical Endocrinology & Metabolism, 2013
- Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)Current Medical Research and Opinion, 2013
- Middle East and North Africa consensus on osteoporosis.2007